avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Gata2
|
ENSMUSG00000015053.8 | GATA binding protein 2 |
Gata1
|
ENSMUSG00000031162.8 | GATA binding protein 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Gata1 | mm10_v2_chrX_-_7964166_7964191 | 0.89 | 2.4e-13 | Click! |
Gata2 | mm10_v2_chr6_+_88198656_88198675 | 0.83 | 3.6e-10 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.3 | 57.9 | GO:0002215 | defense response to nematode(GO:0002215) |
15.0 | 45.1 | GO:0030221 | basophil differentiation(GO:0030221) |
13.2 | 79.4 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
12.8 | 38.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
12.7 | 38.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
12.3 | 98.3 | GO:0015671 | oxygen transport(GO:0015671) |
9.5 | 28.4 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
9.3 | 28.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
8.8 | 52.8 | GO:0031133 | regulation of axon diameter(GO:0031133) |
8.0 | 47.8 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
7.4 | 66.9 | GO:0002432 | granuloma formation(GO:0002432) |
7.4 | 51.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
5.6 | 44.4 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
4.5 | 44.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
3.9 | 38.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
3.8 | 19.1 | GO:2000471 | immunoglobulin biosynthetic process(GO:0002378) regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
3.8 | 30.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
3.3 | 19.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
2.9 | 37.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
2.8 | 33.7 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.5 | 12.7 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
2.5 | 32.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
2.4 | 19.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
2.3 | 16.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
2.2 | 31.3 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
2.2 | 26.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
2.2 | 22.2 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
2.2 | 38.9 | GO:0016075 | rRNA catabolic process(GO:0016075) |
2.2 | 21.5 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
2.1 | 49.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
2.1 | 10.5 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
1.9 | 9.3 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
1.6 | 1.6 | GO:0060529 | squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
1.6 | 61.1 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
1.6 | 32.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.6 | 23.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.5 | 13.9 | GO:0032264 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
1.5 | 37.3 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
1.3 | 7.7 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.2 | 14.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.9 | 2.8 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.9 | 11.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.9 | 23.0 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.9 | 3.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.8 | 12.7 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.8 | 37.8 | GO:0032094 | response to food(GO:0032094) |
0.8 | 1.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.7 | 44.7 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.6 | 5.7 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.6 | 7.2 | GO:0072660 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) |
0.6 | 7.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.5 | 2.9 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.5 | 2.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.5 | 1.4 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.4 | 10.4 | GO:0042730 | fibrinolysis(GO:0042730) |
0.4 | 1.6 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.4 | 2.9 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.4 | 3.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.3 | 3.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 1.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.3 | 22.2 | GO:0001541 | ovarian follicle development(GO:0001541) |
0.3 | 2.3 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.3 | 5.5 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.3 | 18.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.3 | 1.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 4.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.3 | 17.6 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.3 | 2.3 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.2 | 18.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.2 | 9.0 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 0.9 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
0.2 | 5.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 1.6 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 13.7 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 2.7 | GO:0030220 | platelet formation(GO:0030220) |
0.2 | 2.8 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.2 | 6.6 | GO:0030168 | platelet activation(GO:0030168) |
0.2 | 0.3 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 9.9 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.1 | 1.8 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 261.7 | GO:0006508 | proteolysis(GO:0006508) |
0.1 | 0.4 | GO:1901738 | regulation of vitamin A metabolic process(GO:1901738) |
0.1 | 1.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.7 | GO:0046103 | ADP biosynthetic process(GO:0006172) inosine biosynthetic process(GO:0046103) |
0.1 | 11.5 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 0.7 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 4.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 3.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 18.9 | GO:0006887 | exocytosis(GO:0006887) |
0.1 | 0.2 | GO:0051935 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.1 | 2.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.4 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.0 | 0.3 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.0 | 3.3 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) |
0.0 | 0.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.4 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.0 | 0.4 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.3 | 98.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
6.6 | 72.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
3.7 | 37.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
3.1 | 9.3 | GO:0043512 | inhibin-betaglycan-ActRII complex(GO:0034673) inhibin A complex(GO:0043512) |
2.9 | 32.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.4 | 44.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.8 | 30.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.6 | 4.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.5 | 22.3 | GO:0008305 | integrin complex(GO:0008305) |
0.5 | 12.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.5 | 10.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.4 | 74.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.4 | 1.6 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 15.9 | GO:0002102 | podosome(GO:0002102) |
0.3 | 2.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.2 | 56.3 | GO:0042383 | sarcolemma(GO:0042383) |
0.2 | 81.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 18.7 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 17.9 | GO:0005882 | intermediate filament(GO:0005882) |
0.2 | 1.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 1.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.2 | 283.1 | GO:0005615 | extracellular space(GO:0005615) |
0.2 | 18.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 35.5 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 5.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 13.7 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 10.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 49.6 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.1 | 0.7 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 15.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 2.8 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.2 | GO:0071437 | invadopodium(GO:0071437) invadopodium membrane(GO:0071438) |
0.1 | 0.7 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 4.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 11.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.2 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 40.3 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 31.0 | GO:0031410 | cytoplasmic vesicle(GO:0031410) |
0.0 | 2.9 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 75.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 2.8 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 1.6 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 4.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.3 | 98.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
11.3 | 79.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
7.4 | 22.2 | GO:0002113 | interleukin-33 binding(GO:0002113) |
6.3 | 38.0 | GO:0015265 | urea channel activity(GO:0015265) |
6.3 | 69.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
5.7 | 28.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
4.9 | 44.4 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
4.8 | 24.0 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
4.4 | 22.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
4.2 | 21.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
4.1 | 132.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
3.8 | 30.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
3.7 | 11.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
3.1 | 28.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
2.8 | 45.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
2.7 | 32.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
2.5 | 14.9 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
2.0 | 16.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.5 | 13.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.3 | 38.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
1.1 | 8.0 | GO:0016936 | galactoside binding(GO:0016936) |
1.1 | 3.3 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
1.0 | 47.8 | GO:0030552 | cAMP binding(GO:0030552) |
1.0 | 9.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.8 | 12.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.8 | 23.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.8 | 8.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.8 | 167.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.7 | 30.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.7 | 13.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.6 | 43.1 | GO:0030507 | spectrin binding(GO:0030507) |
0.6 | 3.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.6 | 6.3 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.6 | 19.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.5 | 38.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.5 | 68.5 | GO:0005178 | integrin binding(GO:0005178) |
0.5 | 7.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.5 | 26.8 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 1.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.4 | 1.8 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 45.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.4 | 3.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.4 | 13.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 66.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 2.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 7.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 1.6 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 12.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 26.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 13.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 16.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.2 | 2.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 37.1 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.2 | 1.6 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 9.0 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.2 | 43.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 14.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 10.5 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 1.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 2.1 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.6 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 3.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 4.9 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 28.4 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.1 | 0.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 5.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.0 | 0.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 2.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 1.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 2.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 1.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 1.2 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 57.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.2 | 40.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.9 | 22.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.9 | 69.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.9 | 13.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.8 | 66.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.5 | 19.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.4 | 28.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 15.4 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 23.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 16.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 20.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.2 | 54.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 3.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.2 | 7.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 2.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 3.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.6 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 6.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 2.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 28.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.5 | 44.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
1.4 | 28.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
1.3 | 41.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
1.2 | 10.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.9 | 13.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.9 | 21.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.9 | 41.1 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.9 | 19.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.8 | 10.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.8 | 39.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.7 | 13.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.7 | 29.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 13.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 5.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 5.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 60.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 6.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 6.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.3 | 3.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 7.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 18.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.4 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 1.4 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 1.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 4.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 5.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 1.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.3 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |